KRAS inhibitor-23
KRAS inhibitor-23 (Isomer 2 of compound i) is a potent inhibitor of KRAS that plays an important role in cancer research[1].
Product Specifications
CAS Number
2641747-55-7
UNSPSC
12352005
Target
Ras
Type
Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Solubility
10 mM in DMSO
Smiles
O=C1C2=C(N3[C@H](CN(CC3)C(C=C)=O)C(N2C([2H])([2H])[2H])=O)C4=CC(Cl)=C(C5=C(C=CC=C5O)F)N=C4N1C6=C(N=CC=C6C)C(C)C
Molecular Formula
C32H27D3ClFN6O4
Molecular Weight
620.09
References & Citations
[1]GenFleet Therapeutics (Shanghai) Inc., et al. Salt or polymorph of KRAS inhibitor. World Intellectual Property Organization, WO2022223037 A1 2022-10-27
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Isoform
K-Ras
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040745-100 1x 100 µL
CD45 / LCA (2B11 + PD7/26), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040460-100 1x 100 µL
CD44 Standard (156-3C11), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470253-100 1x 100 µL
Cytokeratin, LMW (AE-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042853-100 1x 100 µL
CD54 / ICAM-1 (15.2), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942395-500 1x 500 µL
CD25/ IL2RA (Activated Lymphocyte Marker) (IL2RA/2395), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details